期刊文献+

强化随访结合心电图优化VV间期管理心脏再同步治疗无应答

Management of nonresponder to cardiac resynchronization therapy with disciplinary follow up and electrocardiogram VV interphase optimization
下载PDF
导出
摘要 目的:探讨强化随访结合心电图优化VV间期对心脏再同步治疗(CRT)无应答病人的影响。方法:以2006年1月1日至2011年6月30日在我院植入CRT病人为研究对象,至2012年1月1日CRT应答者为A组,无应答者为B组,存活无应答者为C组,强化随访联合心电图VV间期优化半年后为D组。观察指标为死亡、NYHA心功能分级、6 min步行试验及左室射血分数(EF)。结果:共91例病人入选,经过中位34(6~62)个月随访,41例(占45.1%)对CRT无应答,A组与B组相比,缺血型心肌病及QRS宽度≤120 ms差异有统计学意义(均P<0.001)。经过强化随访半年后25例(占27.5%)对CRT无应答。C组与D组相比,NYHA心功能分级、6 min步行试验、EF、QRS宽度≤120 ms差异有统计学意义(均P<0.01)。常规随访后无应答率(占45.1%)与强化随访后无应答率(占27.5%)相比差异有统计学意义(P<0.01)。结论:缺血型心肌病及QRS宽度≤120 ms可能是无应答主要因素;强化随访结合心电图VV间期优化能改善临床症状以及提高EF。 Objective: To explore the influence of disciplinary follow-up with electrocardiogram optimization VV interphase to nonresponder to cardiac resynchronization therapy. Methods: Patients implanted CRT from January 1, 2006 to June 30, 2011 were selected as the research object. Till January 1 2012, responder was divided as group A, nonresponder as group B, survived group B as group C, after 6 months disciplinary follow-up as group D. To observe death, New York heart function classification, 6 minutes walk distance, EF. Results: A total of 91 patients were included, after the 34(6.0 - 62.0) months median of follow-up, 41 cases (45.1%) were nonresponders, A group compared with B group, ischemic cardiomyopathy and QRS width 〈 120 ms had statis- tic significance (P〈0.001). After 6 months of disciplinary follow-up, 25 cases (27.5%) were nonresponders. New York Heart function classification, six minutes walk distance increased and EF increased (P〈0.01). No response rate of regular follow-up and disciplinary follow-up were 45.1% and 27.5% respectively (P〈0.01). Conclusion: Ischemic cardiomyopathy and QRS width 〈 120 ms may be nonresponders main factors. After the disciplinary follow-up combined with ECG VV interphase optimization, the clinical symptoms and the EF improve.
出处 《温州医学院学报》 CAS 2013年第5期323-325,共3页 Journal of Wenzhou Medical College
关键词 心脏再同步治疗 强化随访 无应答 优化 cardiac resynchronization therapy disciplinary follow up nonresponder optimization
  • 相关文献

参考文献7

  • 1Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantabledefibrillator in advanced chronic heart failure[J]. N Engl JMed, 2004,350(21): 2140-2150.
  • 2Cleland J,Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronization therapy on mor-tality from baseline variables and the early response a re-port from the CARE-HF (Cardiac Resynchronization in HeartFailure) Trial[J]. J Am Coll Cardiol, 2008, 5; 52(6): 438-445.
  • 3Exner DV, Auricchio A, Singh JP. contemparary and futuretrends in cardiac resynchronization therapy to enhanceresponse[J]. Heart Rhythm, 2012, 9(8 Suppl): S27-S35.
  • 4Altman RK,Parks KA, Schlett CL, et al. Multidisciplinarycare of patients receiving cardiac resynchronization therapyis associated with improved clinical outcomes[J]. Eur HeartJ, 2012,33(17): 2181-2188.
  • 5刘铭雅,李云婧,朱伟,魏盟.强化门诊随访对心力衰竭患者预后及依从性的影响[J].中华心血管病杂志,2010,38(7):588-591. 被引量:40
  • 6Tamborero D, Vidal B, Tolosana JM, et al. Electrocardio-graphic versus echocardiographic optimization of the inter-ventricular pacing delay in patients undergoing cardiacresynchronization therapy [J]. J Cardiovasc Electrophysiol,2011’ 22(10): 1129-1134.
  • 7Vidal B,Tamborero D, Mont L, et al. Electrocardiographicoptimization of interventricular delay in cardiac resynch-ronization therapy: a simple method to optimize the device[J]. J Cardiovasc Eleltrophysiol, 2007> 18(12): 1252-1257.

二级参考文献10

  • 1Senni M,Tribouilloy CM,Rodeheffer RJ,et al.Congestive heart failure in the community:trends in incidence and survival in a 10-year period.Arch Intern Med,1999,159:29-34.
  • 2Gonseth J,Cuallar-Castillon P,Banegas JR,et al.The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure:a systematic review and meta-analysis of published reports.Eur Heart J,2004,25:1570-1595.
  • 3Rector T,Kubo S,Cohn J.Patient's self-assessment of their congestive heart failure.Part 2:content,reliability and validity of a new measure,the Minnesota Living with Heart Failure Questionnaire.Heart Failure,1987,3:198-209.
  • 4Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and Endorsed by the European Society of Intensive Care Medicine (ESICM).Eur J Heart Fail,2008,10:933-989.
  • 5Jaarsma T,van der Wai MH,Lesman-Leegte I,et al.Effect of moderate or intensive disease management program on outcome in patients with heart failure; coordinating study evaluating outcomes of advising and counseling in heart failure (COACH).Arch Intern Med,2008,168:316-324.
  • 6Clark RA,Inglis SC,McAlister FA,et al.Telemonitoring or structured telephone support programmes for patients with chronic heart failure:systematic review and meta-analysis.BMJ,2007,334:942.
  • 7Akosah KO,Schaper AM,Havlik P,et al.Improving care for patients with chronic heart failure in the community:the importance of a disease management program.Chest,2002,122:906-912.
  • 8While A,Kiek F.Chronic heart failure:promoting quality of life.Br J Community Nurs,2009,14:54-59.
  • 9Henrick A.Cost-effective outpatient management of persons with heart failure.Prog Cardiovasc Nurs,2001,16:50-56.
  • 10无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3686

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部